Top Tweets for #BLCSM
🚨 Our LinkedIn newsletter is here!
Check it out to learn more about the role of ctDNA MRD testing in muscle-invasive bladder cancer.
Find commentary from Kirollos Hanna, PharmD, BCPS, BCOP, FACCC, FAPO, FHOPA, and Mamta Parikh, MD, MS, inside!
https://t.co/0LU6r6bGcp
#blcsm #MIBC #BladderCancer #Oncology
In an interview from #ASCO26, Tian Zhang (@TiansterZhang) shares insights into highlights in #ADCs for #BladderCancer 🧬🩺💪
Watch: https://t.co/jHmsZgk6Fl
#Oncology #BlcSM #UroOnc #ImmunoOnc
A new phase 2/3 trial is set to evaluate investigational ivonescimab plus enfortumab vedotin vs the current standard of pembrolizumab plus enfortumab vedotin in patients with previously untreated locally advanced or metastatic urothelial carcinoma. #blcsm https://t.co/SsQImev0cG
EA8192, led by @JCensits and @PGrivasMDPhD, is a phase II/III #clinicaltrial of durvalumab and chemotherapy for patients with high grade upper tract urothelial cancer prior to nephroureterectomy. For more: https://t.co/4dphxuN1s4 #blcsm
⭐️Dr. Shameem discusses with @UroDocAsh practical takeaways for community oncologists for the treatment of #MIBC
#OncTwitter #MedTwitter #HemOnc #BladderCancer #blcsm #UroOnc #Oncology #CommunityOncology @Dr_Aggen @BladderCancerUS
⭐️Perioperative Regimens & Future Strategies for Resectable #MIBC
@UroDocAsh @Dr_Aggen Dr.Shameem and Dr.Drakaki 🗣️
👉NIAGARA (durva+Gem/Cis) & KEYNOTE (EV + pembro) regimens
👉Patient selection, toxicities, & bladder preservation
#OncTwitter #MedTwitter
https://t.co/dCCUuqXqGS
A @MayoClinic study found that a new immunotherapy helped patients with aggressive bladder cancer keep their bladder instead of having it removed. @MarkTysonMD @TheLancetOncol #blcsm #oncology
https://t.co/9oIRDjh3cO
Spotlight on cutting edge research led by @zekan_david & @UroCorrea —work being conducted as 2nd yr @SUO_YUO fellow @FCUroOnc
#Blcsm #UroSoMe #SurgEd #2YrFellowshipMattersl
https://t.co/Ourc4TFgy0
Meet BCAN Young Investigator Awardee @zekan_david of @FoxChaseCancer.
"The BCAN Young Investigator's Award provides a springboard for my clinical and research career in bladder cancer. BCAN's support will help ensure our bladder cancer patients are nutritionally optimized at the time of cystectomy to ensure optimal recovery and improve surgical/oncologic outcomes!"
Addition of Intravesical Recombinant Bacillus Calmette-Guérin to Perioperative Chemoimmunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/19
Read the full article. https://t.co/ClvVNHdO13
#blcsm
Addition of Intravesical Recombinant Bacillus Calmette-Guérin to Perioperative Chemoimmunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/19.
Read the full article. https://t.co/ClvVNHdO13
#blcsm
The European Commission approved perioperative pembrolizumab plus enfortumab vedotin for patients with cisplatin-ineligible resectable MIBC. @cvulsteke #blcsm #oncology
https://t.co/LS2gwa5YCc
WATCH 👀: Matthew Galsky, MD, of @TischCancer discusses the standing of immune checkpoint inhibitors in bladder cancer.
See the whole video here ➡️: https://t.co/5EmHLxUAdr
#blcsm #oncology
📢 ¡Nueva edición de @ProjectECHO en Tumores GU!
🌎 El conocimiento necesita viajar. Los pacientes NO
📅 12 de junio
🕗 08:00 hs
💻 Modalidad virtual https://t.co/yP6qceATxZ
"Moviendo conocimiento y no pacientes"
#EducaciónMédica #Blcsm #Pcasm #KCsm #GermTumor #GUOncology
‼️ #ASCO26 simultaneous publication by @AndreaNecchi et al:
Neoadjuvant Sacituzumab Govitecan in Patients With Muscle-Invasive Bladder Cancer: Primary Results of SURE-01 Trial
Read the full article: https://t.co/UCA50bCdGU
#blcsm
WATCH 👀: Joshua J. Meeks, MD, PhD, of @NUFeinbergMed discusses data from a real-world study of BCG retreatment after BCG failure in NMIBC.
See the whole video here ➡️: https://t.co/Ayu9daympE
#blcsm #oncology
Day 1 of #ASCO26 is the one everyone underestimates.
CROWN (7-yr), EV-302 (3.5-yr), CHRYSALIS-2, AcceleRET-Lung, SUCCESSOR-2, LINKER-AL2. And the LBAs to come: RASolute 302, HARMONi-6, LIBRETTO-432, PROTEUS, SERENA-6, NHS-Galleri.
Full breakdown in the article.
#LCSM #blcsm
@OncoAlert @OncBrothers @Larvol
https://t.co/KNaC1qClRu
BREAKING 🚨: @FDAOncology Approves Durvalumab Plus BCG for High-Risk NMIBC
Read more about this decision below! 📰 #blcsm #oncology #FDAapproved https://t.co/qkUPzp2B9j
Last Seen Hashtags on Sotwe
バレットナイツランチャーヘルブレイズ
Seen from Malaysia
momson #teenagee
Seen from Canada
รับงานหนองแขม
Seen from Thailand
momson()* +filter:native_video
Seen from Sweden
nolimits nolimits
Seen from Egypt
teeNager
Seen from Singapore
ankaraesc
Seen from Turkey
plasticpanties
Seen from Argentina
ศาลายา
Seen from Thailand
ديوت_بدوي
Seen from Saudi Arabia
Most Popular Users
Elon Musk 
@elonmusk
241.2M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
112.9M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.3M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.5M followers
KATY PERRY
@katyperry
89M followers
Taylor Swift
@taylorswift13
82.9M followers
Lady Gaga
@ladygaga
74.4M followers
Virat Kohli
@imvkohli
71.9M followers
Kim Kardashian
@kimkardashian
70.5M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
64.9M followers
Bill Gates
@billgates
64.6M followers
The Ellen Show
@theellenshow
62.4M followers
Selena Gomez
@selenagomez
62.1M followers
CNN
@cnn
61.8M followers
X
@x
60.8M followers